Loading insider details...
Beta
Latest Form 4 (Sep 3, 2025): Sale of 96,000 ADAP shares, $950.40.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2025 | Adaptimmune Therapeutics PLC (ADAP) | Sale | 96,000 | $950.40 |
| Jan 17, 2024 | Adaptimmune Therapeutics PLC (ADAP) | Grant/Award | 2,544,432 | n/a |
| Jan 18, 2023 | Adaptimmune Therapeutics PLC (ADAP) | Grant/Award | 1,407,072 | n/a |
| May 24, 2022 | Adaptimmune Therapeutics PLC (ADAP) | Purchase | 39,000 | $11.3K |
| Jan 14, 2022 | Adaptimmune Therapeutics PLC (ADAP) | Grant/Award | 1,407,072 | n/a |
| Jan 12, 2021 | Adaptimmune Therapeutics PLC (ADAP) | Grant/Award | 1,086,816 | n/a |
| Dec 17, 2020 | Adaptimmune Therapeutics PLC (ADAP) | Purchase | 24,000 | $16.6K |
| Jul 1, 2020 | Adaptimmune Therapeutics PLC (ADAP) | Purchase | 33,000 | $53.5K |
| Apr 1, 2020 | Adaptimmune Therapeutics PLC (ADAP) | Grant/Award | 2,500,000 | n/a |